401 related articles for article (PubMed ID: 23902479)
1. Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats.
Rock EM; Sticht MA; Duncan M; Stott C; Parker LA
Br J Pharmacol; 2013 Oct; 170(3):671-8. PubMed ID: 23902479
[TBL] [Abstract][Full Text] [Related]
2. Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats.
Limebeer CL; Vemuri VK; Bedard H; Lang ST; Ossenkopp KP; Makriyannis A; Parker LA
Br J Pharmacol; 2010 Sep; 161(2):336-49. PubMed ID: 20735419
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.
Rock EM; Kopstick RL; Limebeer CL; Parker LA
Br J Pharmacol; 2013 Oct; 170(3):641-8. PubMed ID: 23889598
[TBL] [Abstract][Full Text] [Related]
4. The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex.
Limebeer CL; Rock EM; Mechoulam R; Parker LA
Br J Pharmacol; 2012 Nov; 167(5):1126-36. PubMed ID: 22671779
[TBL] [Abstract][Full Text] [Related]
5. Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus).
O'Brien LD; Limebeer CL; Rock EM; Bottegoni G; Piomelli D; Parker LA
Br J Pharmacol; 2013 Nov; 170(5):1130-6. PubMed ID: 23991698
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in rats.
Parker LA; Mechoulam R
Integr Physiol Behav Sci; 2003; 38(2):133-45. PubMed ID: 14527182
[TBL] [Abstract][Full Text] [Related]
7. Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes.
Dennis I; Whalley BJ; Stephens GJ
Br J Pharmacol; 2008 Jul; 154(6):1349-58. PubMed ID: 18493244
[TBL] [Abstract][Full Text] [Related]
8. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
McPartland JM; Duncan M; Di Marzo V; Pertwee RG
Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544
[TBL] [Abstract][Full Text] [Related]
9. Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea.
Parker LA; Mechoulam R; Schlievert C; Abbott L; Fudge ML; Burton P
Psychopharmacology (Berl); 2003 Mar; 166(2):156-62. PubMed ID: 12528012
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
O'Brien LD; Wills KL; Segsworth B; Dashney B; Rock EM; Limebeer CL; Parker LA
Pharmacol Biochem Behav; 2013 Jan; 103(3):597-602. PubMed ID: 23103902
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
12. The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum.
Ma YL; Weston SE; Whalley BJ; Stephens GJ
Br J Pharmacol; 2008 May; 154(1):204-15. PubMed ID: 18311186
[TBL] [Abstract][Full Text] [Related]
13. Effect of combined doses of Δ
Rock EM; Sullivan MT; Pravato S; Pratt M; Limebeer CL; Parker LA
Psychopharmacology (Berl); 2020 Mar; 237(3):901-914. PubMed ID: 31897571
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
Booker L; Naidu PS; Razdan RK; Mahadevan A; Lichtman AH
Drug Alcohol Depend; 2009 Nov; 105(1-2):42-7. PubMed ID: 19679411
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats.
Sticht MA; Long JZ; Rock EM; Limebeer CL; Mechoulam R; Cravatt BF; Parker LA
Br J Pharmacol; 2012 Apr; 165(8):2425-35. PubMed ID: 21470205
[TBL] [Abstract][Full Text] [Related]
16. Conditioned gaping produced by high dose Δ
DeVuono MV; Hrelja KM; Sabaziotis L; Rajna A; Rock EM; Limebeer CL; Mutch DM; Parker LA
Neuropharmacology; 2018 Oct; 141():272-282. PubMed ID: 30195587
[TBL] [Abstract][Full Text] [Related]
17. Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.
Hill TD; Cascio MG; Romano B; Duncan M; Pertwee RG; Williams CM; Whalley BJ; Hill AJ
Br J Pharmacol; 2013 Oct; 170(3):679-92. PubMed ID: 23902406
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
19. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
20. Pure Δ
Romano B; Pagano E; Orlando P; Capasso R; Cascio MG; Pertwee R; Marzo VD; Izzo AA; Borrelli F
Pharmacol Res; 2016 Nov; 113(Pt A):199-208. PubMed ID: 27498155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]